| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| M-7 |
|
2418577-74-7 |
詳細
|
| tert-butyl (R)-3-(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)propanoate oxalate |
苯磺順阿曲庫銨中間體Ⅱ草酸鹽 |
|
詳細
|
| bis(4-fluorobenzyl)amine hydrochloride |
|
646051-52-7 |
詳細
|
| AZD4205 |
|
2091134-68-6 |
詳細
|
| Isoquinolinium, 2,2′-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1R,1′R,2R,2′S)-, |
順反異構體陽離子形態(tài) |
96946-43-9 |
詳細
|
| SPH5030-SM3-Z2
(S,Z)-2-fluoro-3-(1-methylpyrrolidin-2-yl)acrylic acid Hydrochloride Salt |
SPH5030-SM3-Z2 |
|
詳細
|
| Isoquinolinium, 2,2′-[(3-methyl-1,5-pentanediyl)bis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1R,1′R,2R,2′R)-, benzenesulfonate (1:2) |
3-甲基戊二醇衍生物二苯磺酸鹽 |
1193104-80-1 |
詳細
|
| Asundexianintermediate |
Asundexian中間體 |
2376389-31-8 |
詳細
|
|
(S)-4-((tert-butoxycarbonyl)amino)-2-hydroxybutanoic acid；（S） -4-（（叔丁氧羰基）氨基）-2-羥基丁酸；Boc-(S)-HABA |
207305-60-0 |
詳細
|
| (2R,3R)-2,3-Dihydroxy-4-[[[4-(2-methylpropoxy)phenyl]methyl]amino]-4-oxobutanoic acid |
|
2727061-36-9 |
詳細
|
| 2,2′-(1,5-Pentanediyl) bis[(1R)-1-[(3,4-dimethoxyphenyl)methyl]-3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinepropanoate |
脫甲基胺雜質
游離態(tài) |
64228-84-8 |
詳細
|
| Isoquinolinium, 2-(2-carboxyethyl)-1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1R,2R)-, benzenesulfonate (1:1) |
順式酸苯磺酸鹽 |
1075727-06-8 |
詳細
|
| Levosimendan impurity; 4-(4-(2-(dicyanomethylene)hydrazinyl)phenyl)-3-methyl-4-oxobutanoic acid |
左西孟旦原料藥中雜質 |
141505-33-1 |
詳細
|
| 4-(TRIFLUOROMETHYL)BENZHYDRAZIDE |
對三氟甲基苯甲酰肼 |
339-59-3 |
詳細
|
| 3-Fluoro-4-[[6-methoxy-7-[3-(4-methyl-1-piperidinyl)propoxy]-4-quinolinyl]oxy]benzenamine |
|
1290538-61-2 |
詳細
|
| 1-methylpiperidin-4-yl (4-isobutoxybenzyl)carbamate |
|
|
詳細
|
| Plazomicin impurity PLZA000141 |
普拉米星雜質 PLZA000141 |
|
詳細
|
| 1-[4-(3-Chloropropoxy)-3-methoxyphenyl]ethan-1-one |
|
58113-30-7 |
詳細
|
| BI-6727 intermediate |
BI-6727的母核中間體 |
877676-50-1 |
詳細
|
| N-(4-fluorobenzyl)-1-methylpiperidin-4-amine |
4-（4氟芐基氨基）-1-甲基哌啶 |
359878-47-0 |
詳細
|
| Pradofloxacin HCl |
普多沙星鹽酸鹽 |
195532-14-0 |
詳細
|
| RO3280 intermediate |
RO3280母核中間體 |
1062246-03-0 |
詳細
|
| 2,2'-[hexane-1,6-diylbis[oxy(3-oxopropane-3,1-diyl)]]bis[(1R, 2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium |
己二醇衍生物陽離子形態(tài) |
1193104-84-5 |
詳細
|
| Isoquinolinium, 1-[(3,4-dimethoxyphenyl)methyl]-2-[3-(1,1-dimethylethoxy)-3-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1R,2S)-, benzenesulfonate (1:1) |
反式酯苯磺酸鹽 |
1075727-02-4 |
詳細
|
| WRG-28 |
|
1913291-02-7 |
詳細
|
| Levalbuterol hydrochloride |
鹽酸左沙丁胺醇 |
50293-90-8 |
詳細
|
| 5-methyl-6-phenyl-4,5-dihydropyridazin-3(2H)-one |
|
110766-33-1 |
詳細
|
| Asundexian |
阿舒德克森 |
2064121-65-7 |
詳細
|
| diethyl 2-(2-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)hydrazono)malonate |
|
2445547-93-1 |
詳細
|
| 4-(trifluoromethyl)-N'-(4-(trifluoromethyl)benzoyl)benzohydrazide |
|
69780-61-6 |
詳細
|
| SPH3127 |
|
1399849-02-5 |
詳細
|
| 2,2′-(1,5-Pentanediyl) bis[(1R)-1-[(3,4-dimethoxyphenyl)methyl]-3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinepropanoate |
脫甲基胺雜質的二苯磺酸鹽 |
1253910-09-6 |
詳細
|
| PM-6 |
|
1206789-73-2 |
詳細
|
| 4-isobutoxybenzaldehyde |
|
18962-07-7 |
詳細
|
| Cisatracurium Besylate |
苯磺順阿曲庫銨 |
96946-42-8 |
詳細
|
| (S)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline |
S-勞丹堿 |
2688-77-9 |
詳細
|
| 2-Chloro-5,6,7,8-tetrahydro-1,6-naphthyridine |
2-氯-5,6,7,8-四氫-1,6-萘啶(M-3) |
210539-05-2 |
詳細
|
| Plazomicin impurity PLZA000007 |
普拉米星雜質PLZA000007 |
2306236-37-1 |
詳細
|
| Macitentan |
馬昔騰坦 |
441798-33-0 |
詳細
|
| Tecovirimat |
特考韋瑞；特韋利瑪 |
816458-31-8 |
詳細
|
| SPH3127 2470-C1impurity；methyl (3-(3-carbamoyl-6-methyl-1H-pyrazolo[3,4-b]pyridin-1-yl)propyl)carbamate |
SPH3127 2470-C1雜質 |
|
詳細
|
| 1,1,3-tris(4-isobutoxybenzyl)urea |
|
|
詳細
|
| L-Leucine,N-acetyl-, compd. with (1S)-1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxyisoquinoline (1:1) |
S-四氫罌粟堿-N-乙酰基-L-亮氨酸鹽 |
50720-57-5 |
詳細
|
| Isoquinolinium, 2,2′-[(3-methyl-1,5-pentanediyl)bis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1R,1′R,2R,2′R)-, ) |
3-甲基戊二醇衍生物陽離子形態(tài) |
1193104-79-8 |
詳細
|
| Xanomeline tartrate |
酒石酸沙諾美林 |
152854-19-8 |
詳細
|
| 1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)urea |
|
1388858-78-3 |
詳細
|
| Mefatinib Impurity 5; |
麥華替尼雜質5 |
1417695-78-3 |
詳細
|
| 5-(2-bromoacetyl)-2-hydroxybenzyl acetate |
硫酸沙丁胺醇和鹽酸左沙丁胺醇雜質 |
|
詳細
|
| 6-(4-chlorophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one |
|
1630760-90-5 |
詳細
|
| HRO761 |
|
2869954-34-5 |
詳細
|
| N,N'-((1R,2R)-cyclohexane-1,2-diyl)bis(N-methylpicolinamide) |
|
1116020-87-1 |
詳細
|
| SPH3127 impurityH |
SPH3127雜質H |
|
詳細
|
| Deuterium SPH7050 |
氘代SPH7050 |
|
詳細
|
| ((1R,2R)-2-(3-(tert-butoxy)-3-oxopropyl)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium benzenesulfonate) |
苯磺順阿曲庫銨中間體Ⅲ R順酯 |
1075727-00-2 |
詳細
|
| RO3280 |
|
1062243-51-9 |
詳細
|
| BML-280 intermediate |
BML-280中間體 |
1021-25-6 |
詳細
|
| 6-(4-hydroxyphenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one |
|
103416-88-2 |
詳細
|
| Isoquinolinium, 2-(2-carboxyethyl)-1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1R,2R)-, |
順式酸陽離子形態(tài) |
1075727-04-6 |
詳細
|
| (±)-Laudanosine |
勞丹堿消旋體 |
1699-51-0 |
詳細
|
| AZD4604 |
|
2241039-81-4 |
詳細
|
| Isoquinolinium, 1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-(3-methoxy-3-oxopropyl)-2-methyl-, iodide (1:1), (1R,2R)- |
順酸甲基酯碘鹽 |
1075726-91-8 |
詳細
|
| Plazomicin intermediate PLZA000004 |
普拉米星中間體 PLZA000004 |
2306236-35-9 |
詳細
|
| 6-methoxy-7-[3-(1-pyrrolidinyl)propoxy]-4(1H)-Quinolinone; |
6-甲氧基 -7-(3-吡咯烷 -1-基)丙氧基)喹啉 -4(1H)-酮 |
205448-56-2 |
詳細
|
| Salbutamol sulfate;Albuterol Sulfate |
硫酸沙丁胺醇 |
51022-70-9 |
詳細
|
| NLRP3-IN-25 |
|
2660230-90-8 |
詳細
|
| (1S)-1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxyisoquinoline |
S-四氫罌粟堿
游離堿 |
4747-98-2 |
詳細
|
| 4-(2-(4-(2-(tert-butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)phenoxy)-1-hydroxyethyl)-2-(hydroxymethyl)phenol |
|
|
詳細
|
| Plazomicin impurity PLZC001474 |
普拉米星雜質PLZC001474 |
|
詳細
|
| 7,7-dichlorobicyclo[4.1.0]heptane |
7,7-二氯二環(huán)[4.1.0]庚烷 |
823-69-8 |
詳細
|
| TAK-960 |
|
1137868-52-0 |
詳細
|
| 7,7-dibromobicyclo[4.1.0]heptane |
7,7-二溴雙環(huán)[4.1.0]庚烷 |
2415-79-4 |
詳細
|
|
R-勞丹堿 (R)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline |
85-63-2 |
詳細
|
| VX-150 |
|
1793080-72-4 |
詳細
|
| 4-isobutoxybenzaldehyde oxime |
|
882035-15-6 |
詳細
|
| Plazomicin impurity PLZA000003 |
普拉米星雜質 PLZA000003 |
1154758-55-0 |
詳細
|
| （(R)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline acetyl-L-leucinate） |
R-四氫罌粟堿N-乙?；?L-亮氨酸鹽 |
141109-12-8 |
詳細
|
| bis(4-isobutoxybenzyl)amine hydrochloride |
|
2322278-87-3 |
詳細
|
| 2-[[4-(2-Methylpropoxy)phenyl]methyl]-1H-isoindole-1,3(2H)-dione |
|
21244-29-1 |
詳細
|
| 6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-4-Quinolinol |
|
1494544-04-5 |
詳細
|
| SPH5030-SM3
(R,Z)-2-fluoro-3-(1-methylpyrrolidin-2-yl)acrylic acid |
SPH5030 游離酸 |
2577289-51-9 |
詳細
|
| (E)-1-(4-(3-chloropropoxy)-5-methoxy-2-nitrophenyl)-3-(dimethylamino)prop-2-en-1-one |
|
1449763-02-3 |
詳細
|
| 4-fluorobenzyl (4-isobutoxybenzyl)carbamate |
|
|
詳細
|
| Plazomicin impurity PLZC000049944 |
普拉米星雜質PLZC000049944 |
|
詳細
|
| BML-280 |
|
1158347-73-9 |
詳細
|
| 1,3-bis(4-isobutoxybenzyl)urea |
|
955997-87-2 |
詳細
|
| 2,2'-[hexane-1,6-diylbis[oxy(3-oxopropane-3,1-diyl)]]bis[(1R, 2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium |
己二醇衍生物二苯磺酸鹽 |
1193104-85-6 |
詳細
|
| Isoquinolinium, 2,2′-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1R,1′R,2S,2′S)-, benzenesulfonate (1:2) |
（1R,1’R,2S,2’S）反-反異構體二苯磺酸鹽 |
96946-46-2 |
詳細
|
| Isoquinolinium, 1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-(3-methoxy-3-oxopropyl)-2-methyl-, (1R,2R)- |
順酸甲基酯陽離子形態(tài) |
1075726-87-2 |
詳細
|
| Plazomicin impurity PLZA000005 |
普拉米星雜質 PLZA000005 |
1154758-62-9 |
詳細
|
| Isoquinolinium, 1-[(3,4-dimethoxyphenyl)methyl]-2-[3-(1,1-dimethylethoxy)-3-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1R,2S)-, |
反式酯陽離子形態(tài)： |
1075727-01-3 |
詳細
|
| 2-hydroxy-6-methylnicotinonitrile |
|
4241-27-4 |
詳細
|
| 2-[(2,4-difluorophenyl)methylene]-N-[3-fluoro-4-[[6-methoxy-7-[3-(4-methyl-1-piperidinyl)propoxy]-4-quinolinyl]oxy]phenyl]-, (2E)-Hydrazinecarboxamide |
C-MET抑制劑; |
1428787-71-6 |
詳細
|